Sanofi develops and markets drugs with a concentration in vaccines, immunology, oncology, cardiovascular disease, diabetes, and over-the-counter treatments... Show more
SNY is expected to report earnings to rise 5.03% to $1.67 per share on October 24
Q3'25
Est.
$1.67
Q2'25
Beat
by $0.63
Q1'25
Beat
by $0.12
Q4'24
Beat
by $0.53
Q3'24
Beat
by $0.88
The last earnings report on July 31 showed earnings per share of $1.59, beating the estimate of 95 cents. With 619.52K shares outstanding, the current market capitalization sits at 115.53B.
These past five trading days, the stock lost 0.00% with an average daily volume of 0 shares traded.The stock tracked a drawdown of 0% for this period. SNY showed earnings on July 31, 2025. You can read more about the earnings report here.